Fate Therapeutics' Grant - II Round

Fate Therapeutics raised a round of funding on February 08, 2010. Investors include Qualifying Therapeutic Discovery Project.

Fate Therapeutics (NASDAQ: FATE) is a biotechnology company developing stem cell modulators (SCMs), biologic or small molecule compounds that guide cell fate, to treat patients with very few therapeut…

Articles about Fate Therapeutics' Grant - II Round: